1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Autoimmune Diseases Treatment Market
2.2. Global Autoimmune Diseases Treatment Market, By Type of Threapeutic, 2023 (US$ Million)
2.3. Global Autoimmune Diseases Treatment Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Autoimmune Diseases Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Autoimmune Diseases Treatment Market Vendors
3.2. Strategies Adopted by Autoimmune Diseases Treatment Market Vendors
3.3. Key Industry Strategies
4. Autoimmune Diseases Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Autoimmune Diseases Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Chemical-based Drugs
5.3.1.1. Immunosuppressant Drugs
5.3.1.2. NSAIDs
5.3.1.3. Corticosteroids
5.3.2. Biological Drugs
5.3.3. Pipeline Analysis
5.3.3.1. Projected sales of Phase III Drugs estimated till 2022, by Most Prevalent Autoimmune Diseases (US$ Mn)
5.3.3.1.1. Hashimoto's Thyroiditis
5.3.3.1.2. Type I Diabetes
5.3.3.1.3. Crohn's Disease
5.3.3.1.4. Multiple Sclerosis
5.3.3.1.5. Rheumatoid Arthritis
5.3.3.1.6. Ankylosing Spondylitis
5.3.3.1.7. Systemic Lupus Erythematosus
5.3.3.1.8. Psoriasis
5.3.3.2. Tabular Representation of Phase II and I Drugs


6. North America Autoimmune Diseases Treatment Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
6.3.Autoimmune Diseases Treatment Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)

7. UK and European Union Autoimmune Diseases Treatment Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
7.3.Autoimmune Diseases Treatment Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)

8. Asia Pacific Autoimmune Diseases Treatment Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
8.3.Autoimmune Diseases Treatment Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)

9. Latin America Autoimmune Diseases Treatment Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
9.3.Autoimmune Diseases Treatment Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)

10. Middle East and Africa Autoimmune Diseases Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
10.3.Autoimmune Diseases Treatment Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Autoimmune Diseases Treatment Market: By Type of Threapeutic, 2022-2032, USD (Million)

11. Company Profile
11.1. Genentech Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Bayer AG
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Merck & Co.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Amgen Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Johnson & Johnson Limited
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Abbott Laboratories
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Eli Lilly and Company
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. GlaxoSmithKline Plc
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. F. Hoffmann-La Roche AG
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Bristol Myers Squibb Company.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives